Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|18|7|609-621

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.18, Iss.7, 2018-03, pp. : 609-621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Aromatase Inhibitors in the Treatment of Postmenopausal Breast Cancer

By Bajetta E.  

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 271-283

Adis International

Access to resources Recommend Favorite

Aromatase Inhibitors: A New Reality for the Adjuvant Endocrine Treatment of Early-Stage Breast Cancer in Postmenopausal Women

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 6, 2008-06 ,pp. : 564-574

Bentham Science Publishers

Access to resources Recommend Favorite

Aromatase Inhibitors in Postmenopausal Breast Cancer Patients

By Rieber Alyssa G.   Theriault Richard L.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 3, 2005-05 ,pp. : 309-314

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer

By Michaud L.B.  

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 297-309

Adis International

Access to resources Recommend Favorite